v3.25.2
Income Taxes (Tables)
12 Months Ended
Mar. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of Provision (Benefit) for Income Taxes
The components of the Company’s income tax provision (benefit) attributable to operations are as follows:
Year ended March 31,
202520242023
Current:
U.S. federal$— $— $(38)
State and local— — 637 
Non-U.S.8,241 8,262 10,313 
8,241 8,262 10,912 
Deferred:
U.S. federal(9)5,925 3,026 
State and local— 5,491 (3,430)
Non-U.S.(3,997)(4,361)(5,362)
(4,006)7,055 (5,766)
Income tax provision$4,235 $15,317 $5,146 
Reconciliation of Income Tax Expense Between Statutory U S Income Tax Rate With Actual Income Tax Provision
A reconciliation of income tax expense using the statutory U.S. income tax rate compared with the actual income tax provision follows:
Year ended March 31,
202520242023
Statutory federal income taxes$(18,518)$(85,077)$4,650 
State income taxes, net of federal benefit(2,591)— 77 
State rate remeasurement523 1,680 (2,992)
Non-deductible expenses— 176 67 
Disallowed executive compensation2,018 1,145 1,070 
Excess deductions for stock compensation1,572 2,783 1,167 
Foreign income inclusion, net— — 3,926 
Foreign rate differential(5,049)(544)(2,682)
Impairment of goodwill— 64,346 — 
Research and development tax credit(1,721)(721)(3,000)
Change in uncertain tax liability364 144 600 
Change in valuation allowance29,551 29,010 6,500 
Return-to-provision adjustments(1,976)2,375 (4,237)
Other miscellaneous62 — — 
Income tax provision$4,235 $15,317 $5,146 
Schedule of Deferred Tax Assets and Liabilities
Deferred income tax assets and liabilities consist of the following:
Year ended March 31,
202520242023
Deferred income tax assets
Net operating loss carry-forward$90,177 $74,997 $63,660 
Stock-based compensation5,698 6,527 7,009 
Accrued compensation172 219 1,562 
Capitalized research and experimentation expenses3,114 2,311 4,965 
Disallowed Interest
16,434 7,886 1,366 
Gross deferred income tax assets115,595 91,940 78,562 
Valuation allowance(85,403)(55,852)(25,921)
Net deferred income tax assets30,192 36,088 52,641 
Deferred income tax liabilities
Depreciation and amortization(1,310)(1,427)(2,063)
Intangibles and goodwill(45,190)(55,085)(64,518)
Net deferred income tax assets (liabilities)$(16,308)$(20,424)$(13,940)
Schedule of Operating Loss Carryforwards
The following details the scheduled expiration dates of the Company’s net operating loss (NOL) carryforwards:
2026 Through 20352036 Through 2045IndefiniteTotal
U.S. federal NOLs$— $44,812 $77,833 $122,645 
State taxing jurisdictions NOLs12,398 139,393 4,858 156,649 
Non-U.S. NOLs731 2,205 183,385 186,321 
Total, net$13,129 $186,410 $266,076 $465,615 
Schedule of Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits
A reconciliation of the beginning and ending amounts of unrecognized tax benefits for the years ended March 31, 2025, 2024, and 2023, is as follows:
Year ended March 31,
 202520242023
Balance at April 1$2,168 $2,024 $1,424 
Additions for tax positions of prior years364 144 600 
Reductions for tax positions of prior years— — — 
Balance at March 31$2,532 $2,168 $2,024